XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Parent Company Only Financial Information
 3 Months Ended
Mar. 31, 2022
Condensed Financial Information Disclosure [Abstract]  
Parent Company Only Financial Information Parent Company Only Financial Information
Interim Condensed Balance Sheets
March 31
2022		December 31
2021
ASSETS
Cash on deposit at the Bank$10,094 $11,535 
Investments in subsidiaries164,756 178,395 
Premises and equipment1,469 1,482 
Other assets49,063 48,923 
TOTAL ASSETS$225,382 $240,335 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Subordinated debt, net of unamortized issuance costs
$29,181 $29,158 
Other liabilities359 129 
Shareholders' equity195,842 211,048 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$225,382 $240,335 
Interim Condensed Statements of Income
Three Months Ended 
 March 31
20222021
Income
Dividends from subsidiaries$800 $1,300 
Interest income3 — 
Other income4 6 
Total income807 1,306 
Expenses
Interest expense266 — 
Occupancy and equipment17 16 
Audit, consulting, and legal fees120 118 
Director fees106 85 
Other280 264 
Total expenses789 483 
Income before income tax benefit and equity in undistributed earnings of subsidiaries18 823 
Federal income tax benefit163 100 
Income before equity in undistributed earnings of subsidiaries181 923 
Undistributed earnings of subsidiaries4,553 4,475 
Net income$4,734 $5,398 
Interim Condensed Statements of Cash Flows
Three Months Ended 
 March 31
20222021
Operating activities
Net income$4,734 $5,398 
Adjustments to reconcile net income to cash provided by operations
Undistributed earnings of subsidiaries(4,553)(4,475)
Share-based payment awards under the Directors Plan149 160 
Share-based payment awards under the RSP31 4 
Amortization of subordinated debt issuance costs23 — 
Depreciation13 13 
Changes in operating assets and liabilities which provided (used) cash
Other assets(140)478 
Other liabilities230 1,204 
Net cash provided by (used in) operating activities487 2,782 
Investing activities
Financing activities
Cash dividends paid on common stock(2,031)(2,130)
Proceeds from the issuance of common stock439 387 
Common stock repurchased(185)(1,149)
Common stock purchased for deferred compensation obligations(151)(194)
Net cash provided by (used in) financing activities(1,928)(3,086)
Increase (decrease) in cash and cash equivalents(1,441)(304)
Cash and cash equivalents at beginning of period11,535 2,670 
Cash and cash equivalents at end of period$10,094 $2,366